These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 509846)
1. Unusual Tc-99m and I-123 images in metastatic thyroid adenocarcinoma. Donoghue GD; Steinbach JJ; Winterberger AR Clin Nucl Med; 1979 Nov; 4(11):468-70. PubMed ID: 509846 [TBL] [Abstract][Full Text] [Related]
2. Accumulation of iodine-131 and technetium-99m pertechnetate in thyroid carcinoma. Katagiri M; Suzuki S; Sadahiro S; Kubouchi K; Ohmura T; Tsumura O; Akatsuka S Clin Nucl Med; 1988 Apr; 13(4):276-9. PubMed ID: 2836118 [TBL] [Abstract][Full Text] [Related]
3. Tc-99m-pertechnetate scanning in metastatic thyroid carcinoma: a case report. Lamberigts G; De Roo M; Devos P; Burie D Clin Nucl Med; 1981 Apr; 6(4):172-4. PubMed ID: 7214773 [TBL] [Abstract][Full Text] [Related]
4. Significance of extrathyroidal uptake of Tc-99m and I-123 in the thyroid scan: concise communication. Ryo UY; Stachura ME; Schneider AB; Nichols R; Cogan SR; Pinsky S J Nucl Med; 1981 Dec; 22(12):1039-42. PubMed ID: 7310513 [TBL] [Abstract][Full Text] [Related]
5. The use of technetium-99m pertechnetate in postoperative thyroid carcinoma. A comparative study with iodine-131. Khammash NF; Halkar RK; Abdel-Dayem HM Clin Nucl Med; 1988 Jan; 13(1):17-22. PubMed ID: 2832116 [TBL] [Abstract][Full Text] [Related]
6. Colon carcinoma metastatic to the thyroid gland. Lester JW; Carter MP; Berens SV; Long RF; Caplan GE Clin Nucl Med; 1986 Sep; 11(9):634-5. PubMed ID: 3021377 [TBL] [Abstract][Full Text] [Related]
7. Insensitivity of Tc-99m pertechnetate for detecting metastases of differentiated thyroid carcinoma. Campbell CM; Khafagi FA Clin Nucl Med; 1990 Jan; 15(1):1-4. PubMed ID: 2155079 [TBL] [Abstract][Full Text] [Related]
8. Technetium-99m tetrofosmin uptake in insular thyroid carcinoma. A comparison with iodine-131. Degirmenci B; Aydin A; Comlekci A; Ozdogan O; Bekis R Clin Nucl Med; 2003 May; 28(5):385-8. PubMed ID: 12702934 [TBL] [Abstract][Full Text] [Related]
9. Preoperative scintigraphic detection of cervical metastases from thyroid carcinoma with technetium-99m pertechnetate. Vieras F Clin Nucl Med; 1985 Aug; 10(8):567-9. PubMed ID: 2994934 [TBL] [Abstract][Full Text] [Related]
10. Thyroid carcinoma presenting as an autonomous thyroid nodule. Intenzo CM; Park CH; Cohen SN Clin Nucl Med; 1990 May; 15(5):313-4. PubMed ID: 2160350 [TBL] [Abstract][Full Text] [Related]
11. The value of simultaneous co-registration of 99mTc- MDP and 131Iodine in metastatic differentiated thyroid carcinoma. Kotb MH; Omar W; El-Maghraby T; El-Bedwihy M; El-Tawdy M; Mustafa H; Al-Nahhas A Nucl Med Rev Cent East Eur; 2007; 10(2):98-105. PubMed ID: 18228214 [TBL] [Abstract][Full Text] [Related]
12. Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPET, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer. Iwata M; Kasagi K; Misaki T; Matsumoto K; Iida Y; Ishimori T; Nakamoto Y; Higashi T; Saga T; Konishi J Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):491-8. PubMed ID: 14666387 [TBL] [Abstract][Full Text] [Related]
13. Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma. Alam MS; Takeuchi R; Kasagi K; Misaki T; Miyamoto S; Iida Y; Hidaka A; Konishi J Thyroid; 1997 Oct; 7(5):705-12. PubMed ID: 9349573 [TBL] [Abstract][Full Text] [Related]
14. Localizing functioning thyroid following total thyroidectomy by use of a combination scanning technique. Schmidt MC; Klotch DM; Loré JM Clin Nucl Med; 1980 Sep; 5(9):415-6. PubMed ID: 7408361 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic capabilities of I-131, TI-201, and Tc-99m-MIBI scintigraphy for metastatic differentiated thyroid carcinoma after total thyroidectomy. Fujie S; Okumura Y; Sato S; Akaki S; Katsui K; Himei K; Takemoto M; Kanazawa S Acta Med Okayama; 2005 Jun; 59(3):99-107. PubMed ID: 16049563 [TBL] [Abstract][Full Text] [Related]
16. Differential uptake of 125 I - and 99m TcO 4 - in a histologically unusual metastatic thyroid carcinoma. Schall GL; Roth JA; Temple R J Surg Oncol; 1973; 5(3):235-42. PubMed ID: 4712289 [No Abstract] [Full Text] [Related]
17. Poor results with technetium-99m (V) DMS and iodine-131 MIBG in the imaging of medullary thyroid carcinoma. Hilditch TE; Connell JM; Elliot AT; Murray T; Reed NS J Nucl Med; 1986 Jul; 27(7):1150-3. PubMed ID: 3014086 [TBL] [Abstract][Full Text] [Related]
18. Nuclear medicine approaches in the monitoring of thyroid cancer patients. Sergieva S; Hadjieva T; Doldurova M; Stefanova S; Dudov A J BUON; 2006; 11(4):511-8. PubMed ID: 17309186 [TBL] [Abstract][Full Text] [Related]
19. Recurrent follicular carcinoma-oxyphilic cell type (Hürthle cell carcinoma) of the thyroid, imaging with iodine-131 and technetium-99m tetrofosmin before and after radiotherapy. Bomanji JB; Gacinovic S; Gaze MN; Costa DC; Ell PJ Br J Radiol; 1998 Jan; 71(841):87-9. PubMed ID: 9534706 [TBL] [Abstract][Full Text] [Related]
20. Intense Tl-201 uptake in a "cold" bone lesion due to metastatic thyroid carcinoma. Valdés Olmos RA; Hoefnagel CA; Delprat CC Clin Nucl Med; 1990 Oct; 15(10):735-7. PubMed ID: 2225682 [No Abstract] [Full Text] [Related] [Next] [New Search]